Patient-Centered Acupuncture for Pain (PCAP)
- Conditions
- Cancer Survivors
- Interventions
- Behavioral: Survey
- Registration Number
- NCT02152020
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Brief Summary
The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
- Women or men age 18 years or older
- Primary diagnosis of cancer with history of stage I, II, or III cancer
- Finished primary cancer treatments (surgery, chemotherapy, radiotherapy)
- Have a Karnofsky score of 60 or greater
- Can understand written English
- Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week
- Have been taking pain medications daily
- Have had at least 15 days with pain in the preceding 30 days.
- Women or men with metastatic (stage IV) cancer
- Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks
- Planned surgical procedures in the next 12 weeks
- Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization
- Women who are pregnant or breastfeeding
- Unwillingness to adhere to study related procedures.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cancer survivors Survey -
- Primary Outcome Measures
Name Time Method Number of Adverse Events 12 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Abramson Cancer Center of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States